{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:32:49Z","timestamp":1791059569744,"version":"4.1.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"S12","license":[{"start":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T00:00:00Z","timestamp":1101772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T00:00:00Z","timestamp":1101772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1038\/nm1142","type":"journal-article","created":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T17:02:49Z","timestamp":1101920569000},"page":"S110-S121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":382,"title":["Exotic emerging viral diseases: progress and challenges"],"prefix":"10.1038","volume":"10","author":[{"given":"Thomas W","family":"Geisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,30]]},"reference":[{"key":"BFnm1142_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3201\/eid0805.010284","volume":"8","author":"TW Geisbert","year":"2002","unstructured":"Geisbert, T.W., Pushko, P., Anderson, K., Smith, J. & Davis, K.J. & Jahrling, P.B. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis. 8, 503\u2013507 (2002).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnm1142_CR2","first-page":"89","volume":"133","author":"DH Walker","year":"1987","unstructured":"Walker, D.H. & Murphy, F.A. Pathology and pathogenesis of arenavirus infections. Curr. Top. Microbiol. Immunol. 133, 89\u2013113 (1987).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnm1142_CR3","unstructured":"WHO. Ebola haemorrhagic fever in Sudan, 1976. Report of an international study team. Bull. World Health Organ. 56, 247\u2013270 (1978)."},{"key":"BFnm1142_CR4","unstructured":"WHO. Ebola haemorrhagic fever in Zaire, 1976. Report of an international commission. Bull. World Health Organ. 56, 271\u2013293 (1978)."},{"issue":"Suppl 1","key":"BFnm1142_CR5","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1086\/514306","volume":"179","author":"AS Khan","year":"1999","unstructured":"Khan, A.S. et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179 Suppl 1, S76\u2013S86 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/infdis\/155.3.465","volume":"155","author":"SP Fisher-Hoch","year":"1987","unstructured":"Fisher-Hoch, S.P. et al. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J. Infect. Dis. 155, 465\u2013474 (1987).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01311288","volume":"110","author":"JC Morrill","year":"1990","unstructured":"Morrill, J.C. et al. Pathogenesis of Rift Valley fever in rhesus monkeys: role of the interferon response. Arch. Virol. 110, 195\u2013212 (1990).","journal-title":"Arch. Virol."},{"key":"BFnm1142_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(83)91041-3","volume":"2","author":"SP Fisher-Hoch","year":"1983","unstructured":"Fisher-Hoch, S.P. et al. Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 2, 1055\u20131058 (1983).","journal-title":"Lancet"},{"key":"BFnm1142_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/infdis\/152.5.887","volume":"152","author":"SP Fisher-Hoch","year":"1985","unstructured":"Fisher-Hoch, S.P. et al. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J. Infect. Dis. 152, 887\u2013894 (1985).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR10","first-page":"140","volume":"120","author":"NK Jaax","year":"1996","unstructured":"Jaax, N.K. et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch. Pathol. Lab. Med. 120, 140\u2013155 (1996).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnm1142_CR11","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","volume":"163","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T.W. et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163, 2347\u20132370 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnm1142_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4269\/ajtmh.1973.22.229","volume":"22","author":"B Elsner","year":"1973","unstructured":"Elsner, B., Schwarz, E., Mando, O.G., Maiztegui, J. & Vilches, A. Pathology of 12 fatal cases of Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 22, 229\u2013236 (1973).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jmv.1890220202","volume":"22","author":"KT McKee Jr","year":"1987","unstructured":"McKee, K.T., Jr, Mahlandt, B.G., Maiztegui, J.I., Green, D.E. & Peters, C.J. Virus-specific factors in Argentine hemorrhagic fever in rhesus macaques. J. Med. Virol. 22, 99\u2013111 (1987).","journal-title":"J. Med. Virol."},{"key":"BFnm1142_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","volume":"60","author":"TP Monath","year":"2003","unstructured":"Monath, T.P. & Barrett, A.D. Pathogenesis and pathophysiology of yellow fever. Adv. Virus Res. 60, 343\u2013395 (2003).","journal-title":"Adv. Virus Res."},{"key":"BFnm1142_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/infdis\/132.1.35","volume":"132","author":"JI Maiztegui","year":"1975","unstructured":"Maiztegui, J.I. et al. Ultrastructural and immunohistochemical studies in five cases of Argentine hemorrhagic fever. J. Infect. Dis. 132, 35\u201353 (1975).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","volume":"141","author":"PB Jahrling","year":"1980","unstructured":"Jahrling, P.B. et al. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 141, 580\u2013589 (1980).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR17","first-page":"250","volume":"104","author":"PH Gonzalez","year":"1980","unstructured":"Gonzalez, P.H., Cossio, P.M., Arana, R., Maiztegui, J.I. & Laugens, R.P. Lymphatic tissue in Argentine hemorrhagic fever. Pathologic features. Arch. Pathol. Lab. Med. 104, 250\u2013254 (1980).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnm1142_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0344-0338(11)81176-3","volume":"188","author":"T De Brito","year":"1992","unstructured":"De Brito, T. et al. Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart. Pathol. Res. Pract. 188, 177\u2013181 (1992).","journal-title":"Pathol. Res. Pract."},{"key":"BFnm1142_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0021-9975(92)90043-T","volume":"106","author":"TW Geisbert","year":"1992","unstructured":"Geisbert, T.W., Jahrling, P.B., Hanes, M.A. & Zack, P.M. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J. Comp. Pathol. 106, 137\u2013152 (1992).","journal-title":"J. Comp. Pathol."},{"key":"BFnm1142_CR20","first-page":"839","volume":"121","author":"FJ Burt","year":"1997","unstructured":"Burt, F.J. et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121, 839\u2013846 (1997).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnm1142_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/01913129809032253","volume":"22","author":"TW Geisbert","year":"1998","unstructured":"Geisbert, T.W. & Jaax, N.K. Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct. Pathol. 22, 3\u201317 (1998).","journal-title":"Ultrastruct. Pathol."},{"key":"BFnm1142_CR22","first-page":"97","volume":"235","author":"SR Zaki","year":"1999","unstructured":"Zaki, S.R. & Goldsmith, C.S. Pathologic features of filovirus infections in humans. Curr. Top. Microbiol. Immunol. 235, 97\u2013116 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnm1142_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jmv.10226","volume":"68","author":"AM de Filippis","year":"2002","unstructured":"de Filippis, A.M. et al. Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus. J. Med. Virol. 68, 620\u2013627 (2002).","journal-title":"J. Med. Virol."},{"key":"BFnm1142_CR24","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0002-9440(10)63592-4","volume":"163","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T.W. et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am. J. Pathol. 163, 2371\u20132382 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnm1142_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1099\/0022-1317-76-2-393","volume":"76","author":"S Becker","year":"1995","unstructured":"Becker, S., Spiess, M. & Klenk, H.D. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J. Gen. Virol. 76, 393\u2013399 (1995).","journal-title":"J. Gen. Virol."},{"key":"BFnm1142_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0092-8674(01)00418-4","volume":"106","author":"SY Chan","year":"2001","unstructured":"Chan, S.Y. et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106, 117\u2013126 (2001).","journal-title":"Cell"},{"key":"BFnm1142_CR27","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1128\/JVI.76.13.6841-6844.2002","volume":"76","author":"CP Alvarez","year":"2002","unstructured":"Alvarez, C.P. et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841\u20136844 (2002).","journal-title":"J. Virol."},{"key":"BFnm1142_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/viro.2002.1730","volume":"305","author":"G Simmons","year":"2003","unstructured":"Simmons, G. et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305, 115\u2013123 (2003).","journal-title":"Virology"},{"key":"BFnm1142_CR29","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","volume":"78","author":"A Marzi","year":"2004","unstructured":"Marzi, A. et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78, 12090\u201312095 (2004).","journal-title":"J. Virol."},{"key":"BFnm1142_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/viro.2000.0601","volume":"278","author":"A Takada","year":"2000","unstructured":"Takada, A. et al. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278, 20\u201326 (2000).","journal-title":"Virology"},{"key":"BFnm1142_CR31","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1128\/JVI.78.6.2943-2947.2004","volume":"78","author":"A Takada","year":"2004","unstructured":"Takada, A. et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 78, 2943\u20132947 (2004).","journal-title":"J. Virol."},{"key":"BFnm1142_CR32","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","volume":"282","author":"W Cao","year":"1998","unstructured":"Cao, W. et al. Identification of \u03b1-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282, 2079\u20132081 (1998).","journal-title":"Science"},{"key":"BFnm1142_CR33","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1128\/JVI.76.10.5140-5146.2002","volume":"76","author":"CF Spiropoulou","year":"2002","unstructured":"Spiropoulou, C.F., Kunz, S., Rollin, P.E., Campbell, K.P. & Oldstone, M.B. New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J. Virol. 76, 5140\u20135146 (2002).","journal-title":"J. Virol."},{"key":"BFnm1142_CR34","doi-asserted-by":"crossref","unstructured":"Gallaher, W.R., DiSimone, C. & Buchmeier, M.J. The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol. 1, http:\/\/www.biomedcentral.com\/1471-2180\/1\/1 (2001).","DOI":"10.1186\/1471-2180-1-1"},{"key":"BFnm1142_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/78654","volume":"6","author":"Z Yang","year":"2000","unstructured":"Yang, Z. et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886\u2013889 (2000).","journal-title":"Nat. Med."},{"key":"BFnm1142_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<552::AID-JMV21>3.0.CO;2-A","volume":"59","author":"IS Lukashevich","year":"1999","unstructured":"Lukashevich, I.S. et al. Lassa and Mopeia virus replication in human monocytes\/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J. Med. Virol. 59, 552\u2013560 (1999).","journal-title":"J. Med. Virol."},{"key":"BFnm1142_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/bmj.4.5995.489","volume":"4","author":"JS Gear","year":"1975","unstructured":"Gear, J.S. et al. Outbreake of Marburg virus disease in Johannesburg. Br. Med. J. 4, 489\u2013493 (1975).","journal-title":"Br. Med. J."},{"key":"BFnm1142_CR38","volume-title":"Ebola Virus Haemorrhagic Fever","author":"FA Murphy","year":"1978","unstructured":"Murphy, F.A. Pathology of Ebola virus infection, in Ebola Virus Haemorrhagic Fever (ed Pattyn, S.R.) (Elsevier\/North-Holland Biomedical Press, New York, 1978)."},{"key":"BFnm1142_CR39","first-page":"477","volume":"73","author":"TG Terrell","year":"1973","unstructured":"Terrell, T.G., Stookey, J.L., Eddy, G.A. & Kastello, M.D. Pathology of Bolivian hemorrhagic fever in the rhesus monkey. Am. J. Pathol. 73, 477\u2013494 (1973).","journal-title":"Am. J. Pathol."},{"key":"BFnm1142_CR40","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/jvi.70.4.2208-2214.1996","volume":"70","author":"H Feldmann","year":"1996","unstructured":"Feldmann, H. et al. Filovirus-induced endothelial leakage triggered by infected monocytes\/macrophages. J. Virol. 70, 2208\u20132214 (1996).","journal-title":"J. Virol."},{"key":"BFnm1142_CR41","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.4269\/ajtmh.1982.31.1038","volume":"31","author":"RT Callis","year":"1982","unstructured":"Callis, R.T., Jahrling, P.B. & DePaoli, A. Pathology of Lassa virus infection in the rhesus monkey. Am. J. Trop. Med. Hyg. 31, 1038\u20131045 (1982).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"Suppl 4","key":"BFnm1142_CR42","doi-asserted-by":"publisher","first-page":"S783","DOI":"10.1093\/clinids\/11.Supplement_4.S783","volume":"11","author":"JD Frame","year":"1989","unstructured":"Frame, J.D. Clinical features of Lassa fever in Liberia. Rev. Infect. Dis. 11 Suppl 4, S783\u2013S789 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm1142_CR43","first-page":"434","volume":"83","author":"PL Child","year":"1967","unstructured":"Child, P.L., MacKenzie, R.B., Valverde, L.R. & Johnson, K.M. Bolivian hemorrhagic fever: a pathological description. Arch. Pathol. 83, 434\u2013445 (1967).","journal-title":"Arch. Pathol."},{"key":"BFnm1142_CR44","volume-title":"Marburg Virus Disease","author":"P Gedigk","year":"1971","unstructured":"Gedigk, P., Bechtelsheimer, H. & Korb, G. Pathologic anatomy of the Marburg virus disease, in Marburg Virus Disease (eds Martini, G.A. & Siegert, R.) (Springer-Verlag, New York, 1971)."},{"key":"BFnm1142_CR45","first-page":"535","volume":"52","author":"WC Winn Jr","year":"1975","unstructured":"Winn, W.C., Jr & Walker, D.H. The pathology of human Lassa fever. Bull. World Health Organ. 52, 535\u2013545 (1975).","journal-title":"Bull. World Health Organ."},{"key":"BFnm1142_CR46","first-page":"349","volume":"107","author":"DH Walker","year":"1982","unstructured":"Walker, D.H. et al. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107, 349\u2013356 (1982).","journal-title":"Am. J. Pathol."},{"key":"BFnm1142_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/jmv.1890220203","volume":"22","author":"DE Green","year":"1987","unstructured":"Green, D.E., Mahlandt, B.G. & McKee, K.T., Jr. Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology. J. Med. Virol. 22, 113\u2013133 (1987).","journal-title":"J. Med. Virol."},{"key":"BFnm1142_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ajcp\/25.2.135","volume":"25","author":"NW Elton","year":"1955","unstructured":"Elton, N.W., Romero, A. & Trejos, A. Clinical pathology of yellow fever. Am. J. Clin. Pathol. 25, 135\u2013146 (1955).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnm1142_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-01593-3","volume-title":"Marburg Virus Disease","author":"GA Martini","year":"1971","unstructured":"Martini, G.A. Marburg virus disease: clinical syndrome, in Marburg Virus Disease (eds Martini, G.A. & Siegert, R.) (Springer-Verlag, New York, 1971)."},{"key":"BFnm1142_CR50","first-page":"722","volume":"68","author":"JR Joubert","year":"1985","unstructured":"Joubert, J.R., King, J.B., Rossouw, D.J. & Cooper, R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S. Afr. Med. J. 68, 722\u2013728 (1985).","journal-title":"S. Afr. Med. J."},{"key":"BFnm1142_CR51","first-page":"5","volume":"134","author":"CJ Peters","year":"1987","unstructured":"Peters, C.J., Jahrling, P.B., Liu, C.T., Kenyon, R.H. & McKee, K.T., Jr. & Barrera Oro, J.G. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 134, 5\u201368 (1987).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnm1142_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF01311021","volume":"99","author":"CJ Peters","year":"1988","unstructured":"Peters, C.J. et al. Experimental Rift Valley fever in rhesus macaques. Arch. Virol. 99, 31\u201344 (1988).","journal-title":"Arch. Virol."},{"key":"BFnm1142_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/jmv.1890260204","volume":"26","author":"SP Fisher-Hoch","year":"1988","unstructured":"Fisher-Hoch, S.P., McCormick, J.B., Sasso, D. & Craven, R.B. Hematologic dysfunction in Lassa fever. J. Med. Virol. 26, 127\u2013135 (1988).","journal-title":"J. Med. Virol."},{"issue":"Suppl 4","key":"BFnm1142_CR54","doi-asserted-by":"publisher","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","volume":"11","author":"R Swanepoel","year":"1989","unstructured":"Swanepoel, R. et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11 Suppl 4, S794\u2013S800 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm1142_CR55","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/infdis\/166.4.753","volume":"166","author":"SP Fisher-Hoch","year":"1992","unstructured":"Fisher-Hoch, S.P. et al. Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J. Infect. Dis. 166, 753\u2013763 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR56","volume-title":"Fields Virology","author":"A Sanchez","year":"2001","unstructured":"Sanchez, A. et al. Filoviridae: Marburg and Ebola viruses, in Fields Virology (eds Knipe, D.S. & Howley, P.M.) (Lippincott Williams & Wilkins, Philadelphia, 2001)."},{"key":"BFnm1142_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1286-4579(01)01508-8","volume":"4","author":"H Schmitz","year":"2002","unstructured":"Schmitz, H. et al. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 4, 43\u201350 (2002).","journal-title":"Microbes Infect."},{"key":"BFnm1142_CR58","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/422000","volume":"39","author":"O Ergonul","year":"2004","unstructured":"Ergonul, O. et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin. Infect. Dis. 39, 284\u2013287 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm1142_CR59","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4269\/ajtmh.1978.27.822","volume":"27","author":"CG McLeod Jr","year":"1978","unstructured":"McLeod, C.G., Jr, Stookey, J.L., White, J.D., Eddy, G.A. & Fry, G.A. Pathology of Bolivian Hemorrhagic fever in the African green monkey. Am. J. Trop. Med. Hyg. 27, 822\u2013826 (1978).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR60","volume-title":"Clincal Virology","author":"CJ Peters","year":"1997","unstructured":"Peters, C.J. Arenaviruses, in Clincal Virology (Eds Richman, D.D., Whitley, R.J. & Hayden, F.G.) (Churchill Livingstone, New York, 1997)."},{"key":"BFnm1142_CR61","first-page":"419","volume":"4","author":"N Hudson","year":"1928","unstructured":"Hudson, N. The pathology of experimental yellow fever in the Macaca rhesus. III. Comparison with the pathology of yellow fever in man. Am. J. Pathol. 4, 419\u2013439 (1928).","journal-title":"Am. J. Pathol."},{"key":"BFnm1142_CR62","first-page":"655","volume":"6","author":"O Klotz","year":"1930","unstructured":"Klotz, O. & Belt, T.H. Pathology in spleen in yellow fever. Am. J. Pathol. 6, 655\u2013662 (1930).","journal-title":"Am. J. Pathol."},{"key":"BFnm1142_CR63","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0035-9203(69)90003-0","volume":"63","author":"I Zlotnik","year":"1969","unstructured":"Zlotnik, I. Marburg agent disease: Pathology. Trans. R. Soc. Trop. Med. Hyg. 63, 310\u2013323 (1969).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnm1142_CR64","first-page":"279","volume":"24","author":"FA Murphy","year":"1971","unstructured":"Murphy, F.A., Simpson, D.I.H., Whitfield, S.G., Zlotnik, I. & Carter, G.B. Marburg virus infection in monkeys. Lab. Invest. 24, 279\u2013291 (1971).","journal-title":"Lab. Invest."},{"key":"BFnm1142_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0035-9203(72)90268-4","volume":"66","author":"GM Edington","year":"1972","unstructured":"Edington, G.M. & White, H.A. The pathology of Lassa fever. Trans. R. Soc. Trop. Med. Hyg. 66, 381\u2013389 (1972).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnm1142_CR66","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4269\/ajtmh.1981.30.431","volume":"30","author":"TP Monath","year":"1981","unstructured":"Monath, T.P., Brinker, K.R., Chandler, F.W., Kemp, G.E. & Cropp, C.B. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am. J. Trop. Med. Hyg. 30, 431\u2013443 (1981).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR67","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/jcp.34.8.871","volume":"34","author":"A Baskerville","year":"1981","unstructured":"Baskerville, A., Satti, A., Murphy, F.A. & Simpson, D.I. Congo-Crimean haemorrhagic fever in Dubai: histopathological studies. J. Clin. Pathol. 34, 871\u2013874 (1981).","journal-title":"J. Clin. Pathol."},{"key":"BFnm1142_CR68","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0035-9203(69)90002-9","volume":"63","author":"DIH Simpson","year":"1969","unstructured":"Simpson, D.I.H. Marburg agent disease: in monkeys. Trans. R. Soc. Trop. Med. Hyg. 63, 303\u2013309 (1969).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnm1142_CR69","volume-title":"Marburg Virus Disease","author":"K Havemann","year":"1971","unstructured":"Havemann, K. & Schmidt, H.A. Haematological findings in Marburg virus disease: evidence for involvement of the immunological system, in Marburg Virus Disease (eds Martini, G.A. & Siegert, R.) (Springer-Verlag, New York, 1971)."},{"key":"BFnm1142_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/infdis\/133.1.57","volume":"133","author":"MD Kastello","year":"1976","unstructured":"Kastello, M.D., Eddy, G.A. & Kuehne, R.W. A rhesus monkey model for the study of Bolivian hemorrhagic fever. J. Infect. Dis. 133, 57\u201362 (1976).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4269\/ajtmh.1977.26.159","volume":"26","author":"FS Wagner","year":"1977","unstructured":"Wagner, F.S., Eddy, G.A. & Brand, O.M. The African green monkey as an alternate primate host for studying Machupo virus infection. Am. J. Trop. Med. Hyg. 26, 159\u2013162 (1977).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1073\/pnas.86.1.317","volume":"86","author":"SP Fisher-Hoch","year":"1989","unstructured":"Fisher-Hoch, S.P. et al. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 86, 317\u2013321 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1142_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jmv.1890270218","volume":"27","author":"DA Vallejos","year":"1989","unstructured":"Vallejos, D.A., Ambrosio, A.M., Feuillade, M.R. & Maiztegui, J.I. Lymphocyte subsets alteration in patients with Argentine hemorrhagic fever. J. Med. Virol. 27, 160\u2013163 (1989).","journal-title":"J. Med. Virol."},{"key":"BFnm1142_CR74","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","volume":"78","author":"A Sanchez","year":"2004","unstructured":"Sanchez, A. et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J. Virol. 78, 10370\u201310377 (2004).","journal-title":"J. Virol."},{"key":"BFnm1142_CR75","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/7422","volume":"5","author":"S Baize","year":"1999","unstructured":"Baize, S. et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5, 423\u2013426 (1999).","journal-title":"Nat. Med."},{"key":"BFnm1142_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/labinvest.3780021","volume":"80","author":"TW Geisbert","year":"2000","unstructured":"Geisbert, T.W. et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 80, 171\u2013186 (2000).","journal-title":"Lab. Invest."},{"key":"BFnm1142_CR77","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/vim.2004.17.390","volume":"17","author":"DS Reed","year":"2004","unstructured":"Reed, D.S., Hensley, L.E., Geisbert, J.B., Jahrling, P.B. & Geisbert, T.W. Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol. 17, 390\u2013400 (2004).","journal-title":"Viral Immunol."},{"key":"BFnm1142_CR78","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","volume":"80","author":"LE Hensley","year":"2002","unstructured":"Hensley, L.E., Young, H.A., Jahrling, P.B. & Geisbert, T.W. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80, 169\u2013179 (2002).","journal-title":"Immunol. Lett."},{"key":"BFnm1142_CR79","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1089\/ars.2000.2.4-673","volume":"2","author":"A Takabayashi","year":"2000","unstructured":"Takabayashi, A. et al. Nitric oxide induces a decrease in the mitochondrial membrane potential of peripheral blood lymphocytes, especially in natural killer cells. Antioxid. Redox Signal. 2, 673\u2013680 (2000).","journal-title":"Antioxid. Redox Signal."},{"key":"BFnm1142_CR80","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","volume":"170","author":"S Mahanty","year":"2003","unstructured":"Mahanty, S. et al. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170, 2797\u20132801 (2003).","journal-title":"J. Immunol."},{"key":"BFnm1142_CR81","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-4615-5357-1_28","volume":"451","author":"PT Daniel","year":"1998","unstructured":"Daniel, P.T., Scholz, C., Westermann, J., Dorken, B. & Pezzutto, A. Dendritic cells prevent CD95 mediated T lymphocyte death through costimulatory signals. Adv. Exp. Med. Biol. 451, 173\u2013177 (1998).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnm1142_CR82","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","volume":"172","author":"S Baize","year":"2004","unstructured":"Baize, S. et al. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172, 2861\u20132869 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1142_CR83","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1074-7613(01)00239-4","volume":"15","author":"MJ Raftery","year":"2001","unstructured":"Raftery, M.J. et al. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15, 997\u20131009 (2001).","journal-title":"Immunity"},{"key":"BFnm1142_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-5793(92)80662-Z","volume":"305","author":"VE Volchkov","year":"1992","unstructured":"Volchkov, V.E., Blinov, V.M. & Netesov, S.V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305, 181\u2013184 (1992).","journal-title":"FEBS Lett."},{"key":"BFnm1142_CR85","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0014-5793(93)81476-G","volume":"323","author":"A Bukreyev","year":"1993","unstructured":"Bukreyev, A., Volchkov, V.E., Blinov, V.M. & Netesov, S.V. The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett. 323, 183\u2013187 (1993).","journal-title":"FEBS Lett."},{"key":"BFnm1142_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0002-9343(91)90069-A","volume":"91","author":"T Calandra","year":"1991","unstructured":"Calandra, T., Gerain, J., Heumann, D. & Baumgartner, J.D. & Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am. J. Med. 91, 23\u201329 (1991).","journal-title":"Am. J. Med."},{"key":"BFnm1142_CR87","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00000658-199204000-00009","volume":"215","author":"P Damas","year":"1992","unstructured":"Damas, P. et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215, 356\u2013362 (1992).","journal-title":"Ann. Surg."},{"key":"BFnm1142_CR88","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/00003246-199404000-00025","volume":"22","author":"C Marty","year":"1994","unstructured":"Marty, C. et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit. Care Med. 22, 673\u2013679 (1994).","journal-title":"Crit. Care Med."},{"key":"BFnm1142_CR89","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/infdis\/149.3.428","volume":"149","author":"SC Levis","year":"1984","unstructured":"Levis, S.C. et al. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 149, 428\u2013433 (1984).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR90","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/jir.1985.5.383","volume":"5","author":"SC Levis","year":"1985","unstructured":"Levis, S.C. et al. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5, 383\u2013389 (1985).","journal-title":"J. Interferon Res."},{"key":"BFnm1142_CR91","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/infdis\/166.5.1203","volume":"166","author":"MV Heller","year":"1992","unstructured":"Heller, M.V., Saavedra, M.C., Falcoff, R., Maiztegui, J.I. & Molinas, F.C. Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever. J. Infect. Dis. 166, 1203\u20131204 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR92","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4269\/ajtmh.1999.60.85","volume":"60","author":"RF Marta","year":"1999","unstructured":"Marta, R.F. et al. Proinflammatory cytokines and elastase-\u03b1-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 60, 85\u201389 (1999).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"Suppl 1","key":"BFnm1142_CR93","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1086\/514283","volume":"179","author":"F Villinger","year":"1999","unstructured":"Villinger, F. et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179 Suppl 1, S188\u2013S191 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR94","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0165-2478(99)00169-8","volume":"71","author":"GM Ignatiev","year":"2000","unstructured":"Ignatiev, G.M., Dadaeva, A.A., Luchko, S.V. & Chepurnov, A.A. Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs. Immunol. Lett. 71, 131\u2013140 (2000).","journal-title":"Immunol. Lett."},{"key":"BFnm1142_CR95","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1086\/320722","volume":"183","author":"S Mahanty","year":"2001","unstructured":"Mahanty, S. et al. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 183, 1713\u20131721 (2001).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR96","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1086\/425016","volume":"190","author":"J Ter Meulen","year":"2004","unstructured":"Ter Meulen, J. et al. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J. Infect. Dis. 190, 1821\u20131827 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR97","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","volume":"75","author":"U Stroher","year":"2001","unstructured":"Stroher, U. et al. Infection and activation of monocytes by Marburg and Ebola viruses. J. Virol. 75, 11025\u201311033 (2001).","journal-title":"J. Virol."},{"key":"BFnm1142_CR98","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1160\/TH02-09-0043","volume":"90","author":"RM Gomez","year":"2003","unstructured":"Gomez, R.M. et al. Endothelial cell function alteration after Junin virus infection. Thromb. Haemost. 90, 326\u2013333 (2003).","journal-title":"Thromb. Haemost."},{"key":"BFnm1142_CR99","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/S0140-6736(00)02405-3","volume":"355","author":"EM Leroy","year":"2000","unstructured":"Leroy, E.M. et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355, 2210\u20132215 (2000).","journal-title":"Lancet"},{"key":"BFnm1142_CR100","doi-asserted-by":"publisher","first-page":"S743","DOI":"10.1093\/clinids\/11.Supplement_4.S743","volume":"11","author":"CJ Peters","year":"1989","unstructured":"Peters, C.J., Liu, C.T., Anderson, G.W., Jr, Morrill, J.C. & Jahrling, P.B. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev. Infect. Dis. 11 Suppl 4, S743\u2013S749 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm1142_CR101","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1128\/JVI.78.6.3162-3169.2004","volume":"78","author":"M Asper","year":"2004","unstructured":"Asper, M. et al. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J. Virol. 78, 3162\u20133169 (2004).","journal-title":"J. Virol."},{"key":"BFnm1142_CR102","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1365-2893.1998.00103.x","volume":"5","author":"GR Foster","year":"1998","unstructured":"Foster, G.R. & Finter, N.B. Are all type I human interferons equivalent? J. Viral Hepat. 5, 143\u2013152 (1998).","journal-title":"J. Viral Hepat."},{"key":"BFnm1142_CR103","doi-asserted-by":"publisher","first-page":"12289","DOI":"10.1073\/pnas.220398297","volume":"97","author":"CF Basler","year":"2000","unstructured":"Basler, C.F. et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 97, 12289\u201312294 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1142_CR104","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","volume":"77","author":"CF Basler","year":"2003","unstructured":"Basler, C.F. et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77, 7945\u20137956 (2003).","journal-title":"J. Virol."},{"key":"BFnm1142_CR105","volume-title":"Ebola and Marburg viruses: molecular and cellular biology","author":"CF Basler","year":"2004","unstructured":"Basler, C.F. & Palese, P. Modulation of innate immunity by filoviruses, in Ebola and Marburg viruses: molecular and cellular biology (eds Klenk, H.D. & Feldmann, H) (Horizon Bioscience, Norfolk, UK, 2004)."},{"key":"BFnm1142_CR106","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","volume":"75","author":"M Bouloy","year":"2001","unstructured":"Bouloy, M. et al. Genetic evidence for an interferon-antagonist function of rift valley fever virus nonstructural protein NSs. J. Virol. 75, 1371\u20131377 (2001).","journal-title":"J. Virol."},{"key":"BFnm1142_CR107","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8","volume":"190","author":"H Li","year":"2000","unstructured":"Li, H. & Forstermann, U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190, 244\u2013254 (2000).","journal-title":"J. Pathol."},{"key":"BFnm1142_CR108","first-page":"239","volume":"13","author":"EF Mammen","year":"2000","unstructured":"Mammen, E.F. Disseminated intravascular coagulation (DIC). Clin. Lab. Sci. 13, 239\u2013245 (2000).","journal-title":"Clin. Lab. Sci."},{"key":"BFnm1142_CR109","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1046\/j.1365-2141.2003.04790.x","volume":"124","author":"M Levi","year":"2004","unstructured":"Levi, M. Current understanding of disseminated intravascular coagulation. Br. J. Haematol. 124, 567\u2013576 (2004).","journal-title":"Br. J. Haematol."},{"key":"BFnm1142_CR110","first-page":"457","volume":"13","author":"GA Martini","year":"1968","unstructured":"Martini, G.A., Knauff, H.G., Schmidt, H.A., Mayer, G. & Baltzer, G. A hitherto unknown infectious disease contracted from monkeys. \u201cMarburg-virus\u201d disease. Ger. Med. Mon. 13, 457\u2013470 (1968).","journal-title":"Ger. Med. Mon."},{"issue":"suppl. Suppl 1","key":"BFnm1142_CR111","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/514308","volume":"179","author":"MA Bwaka","year":"1999","unstructured":"Bwaka, M.A. et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J. Infect. Dis. 179 suppl. Suppl 1, S1\u2013S7 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR112","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0035-9203(78)90058-5","volume":"72","author":"ET Bowen","year":"1978","unstructured":"Bowen, E.T., Platt, G.S., Simpson, D.I., McArdell, L.B. & Raymond, R.T. Ebola haemorrhagic fever: experimental infection of monkeys. Trans. R. Soc. Trop. Med. Hyg. 72, 188\u2013191 (1978).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnm1142_CR113","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","volume":"362","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T.W. et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys. Lancet 362, 1953\u20131958 (2003).","journal-title":"Lancet"},{"key":"BFnm1142_CR114","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4269\/ajtmh.1964.13.620","volume":"13","author":"RB Mackenzie","year":"1964","unstructured":"Mackenzie, R.B., Beye, H.K. & Valverde, L. & Garr'on, H. Epidemic hemorrhagic fever in Bolivia. I. A preliminary report of the epidemiological and clinical findings in a new epidemic area in South America. Am. J. Trop. Med. Hyg. 13, 620\u2013625 (1964).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR115","volume-title":"Atlas of Infectious Diseases","author":"CJ Peters","year":"1997","unstructured":"Peters, C.J., Zaki, S.R. & Rollin, P.E. Viral hemorrhagic fevers, in Atlas of Infectious Diseases Vol. 3 (ed Feteky, R.) (Churchill Livingstone, Philadelphia, 1997)."},{"key":"BFnm1142_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/143.1.1","volume":"143","author":"FC Molinas","year":"1981","unstructured":"Molinas, F.C., de Bracco, M.M. & Maiztegui, J.I. Coagulation studies in Argentine hemorrhagic fever. J. Infect. Dis. 143, 1\u20136 (1981).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR117","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2141.1969.tb01393.x","volume":"17","author":"LH Dennis","year":"1969","unstructured":"Dennis, L.H., Reisberg, B.E., Crosbie, J., Crozier, D. & Conrad, M.E. The original haemorrhagic fever: yellow fever. Br. J. Haematol. 17, 455\u2013462 (1969).","journal-title":"Br. J. Haematol."},{"key":"BFnm1142_CR118","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4269\/ajtmh.1978.27.1232","volume":"27","author":"SK Scott","year":"1978","unstructured":"Scott, S.K. et al. Studies of the coagulation system and blood pressure during experimental Bolivian hemorrhagic fever in rhesus monkeys. Am. J. Trop. Med. Hyg. 27, 1232\u20131239 (1978).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR119","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jmv.1890120408","volume":"12","author":"FC Molinas","year":"1983","unstructured":"Molinas, F.C. et al. Alteration of blood coagulation and complement system in neotropical primates infected with Junin virus. J. Med. Virol. 12, 281\u2013292 (1983).","journal-title":"J. Med. Virol."},{"key":"BFnm1142_CR120","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/0140-6736(91)91899-6","volume":"338","author":"R Salas","year":"1991","unstructured":"Salas, R. et al. Venezuelan haemorrhagic fever. Lancet 338, 1033\u20131036 (1991).","journal-title":"Lancet"},{"key":"BFnm1142_CR121","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/s-0038-1653782","volume":"73","author":"MV Heller","year":"1995","unstructured":"Heller, M.V. et al. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb. Haemost. 73, 368\u2013373 (1995).","journal-title":"Thromb. Haemost."},{"key":"BFnm1142_CR122","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1086\/379724","volume":"188","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T.W. et al. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event. J. Infect. Dis. 188, 1618\u20131629 (2003).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR123","first-page":"389","volume":"31","author":"J Knobloch","year":"1980","unstructured":"Knobloch, J. et al. Clinical obersvations in 42 patients with Lassa fever. Tropenmed. Parasitol. 31, 389\u2013398 (1980).","journal-title":"Tropenmed. Parasitol."},{"key":"BFnm1142_CR124","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4269\/ajtmh.1985.34.999","volume":"34","author":"JV Lange","year":"1985","unstructured":"Lange, J.V. et al. Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys. Am. J. Trop. Med. Hyg. 34, 999\u20131007 (1985).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR125","first-page":"50","volume":"66","author":"JJ Rippey","year":"1984","unstructured":"Rippey, J.J., Schepers, N.J. & Gear, J.H. The pathology of Marburg virus disease. S. Afr. Med. J. 66, 50\u201354 (1984).","journal-title":"S. Afr. Med. J."},{"key":"BFnm1142_CR126","volume-title":"Ebola Virus Haemorrhagic Fever","author":"M Isaacson","year":"1978","unstructured":"Isaacson, M., Sureua, P., Courtielle, G. & Pattyn, S.R. Clinical aspects of Ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976, in Ebola Virus Haemorrhagic Fever (ed. Pattyn, S.R.) (Elsevier\/North-Holland Biomedical Press, New York, 1978)."},{"key":"BFnm1142_CR127","first-page":"9","volume":"9","author":"F Santos","year":"1973","unstructured":"Santos, F. et al. Coagulacao intravascular diseminada aguda na febre amarela: dosagem dos factores da coagulacao. Brasilia Med. 9, 9\u201316 (1973).","journal-title":"Brasilia Med."},{"key":"BFnm1142_CR128","first-page":"967","volume":"85","author":"G Grignani","year":"2000","unstructured":"Grignani, G. & Maiolo, A. Cytokines and hemostasis. Haematologica 85, 967\u2013972 (2000).","journal-title":"Haematologica"},{"key":"BFnm1142_CR129","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1161\/01.ATV.17.12.3399","volume":"17","author":"F-J Neumann","year":"1997","unstructured":"Neumann, F-J. et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler. Thromb. Vasc. Biol. 17, 3399\u20133405 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm1142_CR130","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1126\/science.1057269","volume":"291","author":"VE Volchkov","year":"2001","unstructured":"Volchkov, V.E. et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291, 1965\u20131969 (2001).","journal-title":"Science"},{"key":"BFnm1142_CR131","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/JVI.76.1.406-410.2002","volume":"76","author":"G Neumann","year":"2002","unstructured":"Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I. & Kawaoka, Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J. Virol. 76, 406\u2013410 (2002).","journal-title":"J. Virol."},{"key":"BFnm1142_CR132","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1128\/JVI.77.10.5997-6006.2003","volume":"77","author":"R Flick","year":"2003","unstructured":"Flick, R., Flick, K., Feldmann, H. & Elgh, F. Reverse genetics for Crimean-Congo hemorrhagic fever virus. J. Virol. 77, 5997\u20136006 (2003).","journal-title":"J. Virol."},{"key":"BFnm1142_CR133","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1099\/vir.0.18860-0","volume":"84","author":"PJ Bredenbeek","year":"2003","unstructured":"Bredenbeek, P.J. et al. A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J. Gen. Virol. 84, 1261\u20131268 (2003).","journal-title":"J. Gen. Virol."},{"key":"BFnm1142_CR134","doi-asserted-by":"publisher","first-page":"15190","DOI":"10.1073\/pnas.0405759101","volume":"101","author":"KH Rubins","year":"2004","unstructured":"Rubins, K.H. et al. Systematic analysis of the gene expression program in peripheral blood cells in response to systemic smallpox infection. Proc. Natl. Acad. Sci. USA 101, 15190\u201315195 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1142_CR135","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.274.5289.998","volume":"274","author":"MR Emmert-Buck","year":"1996","unstructured":"Emmert-Buck, M.R. et al. Laser capture microdissection. Science 274, 998\u20131001 (1996).","journal-title":"Science"},{"key":"BFnm1142_CR136","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.278.5342.1481","volume":"278","author":"RF Bonner","year":"1997","unstructured":"Bonner, R.F. et al. Laser capture microdissection: molecular analysis of tissue. Science 278, 1481, 1483 (1997).","journal-title":"Science"},{"key":"BFnm1142_CR137","volume-title":"Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. Told From the Inside by the Man Who Ran It","author":"K Alibek","year":"1999","unstructured":"Alibek, K. & Handelman, S. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. Told From the Inside by the Man Who Ran It (Random House, New York, 1999)."},{"key":"BFnm1142_CR138","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","volume":"1","author":"TP Monath","year":"2001","unstructured":"Monath, T.P. Yellow fever: an update. Lancet Infect. Dis. 1, 11\u201320 (2001).","journal-title":"Lancet Infect. Dis."},{"key":"BFnm1142_CR139","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1086\/514211","volume":"177","author":"JI Maiztegui","year":"1998","unstructured":"Maiztegui, J.I. et al. (1998) Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J. Infect. Dis. 177, 277\u2013283 (1998).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR140","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","volume":"18","author":"PR Pittman","year":"1999","unstructured":"Pittman, P.R. et al. Immunogenicity of an inactivated Rift Valley fever vaccine in humans. Vaccine 18, 181\u2013189 (1999).","journal-title":"Vaccine"},{"key":"BFnm1142_CR141","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1586\/14760584.2.6.777","volume":"2","author":"TW Geisbert","year":"2003","unstructured":"Geisbert, T.W. & Jahrling, P.B. Towards a vaccine against Ebola virus. Expert Rev. Vaccines 2, 777\u2013789 (2003).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnm1142_CR142","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/14760584.3.2.189","volume":"3","author":"SP Fisher-Hoch","year":"2004","unstructured":"Fisher-Hoch, S.P. & McCormick, J.B. Lassa fever vaccine. Expert Rev. Vaccines 3, 189\u2013197 (2004).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnm1142_CR143","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","volume":"74","author":"SP Fisher-Hoch","year":"2000","unstructured":"Fisher-Hoch, S.P., Hutwagner, L., Brown, B. & McCormick, J.B. Effective vaccine for Lassa fever. J. Virol. 74, 6777\u20136783 (2000).","journal-title":"J. Virol."},{"key":"BFnm1142_CR144","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/35046108","volume":"408","author":"NJ Sullivan","year":"2000","unstructured":"Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z-Y. & Nabel, G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605\u2013609 (2000).","journal-title":"Nature"},{"key":"BFnm1142_CR145","doi-asserted-by":"crossref","unstructured":"Sullivan, N.J. et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681\u2013684.","DOI":"10.1038\/nature01876"},{"key":"BFnm1142_CR146","unstructured":"Jones, S. et al. Replicating vectors for vaccine development. VRC Symposium on Viral Hemorrhagic Fevers, Bethesda, MD, October 14\u201317, 2003."},{"key":"BFnm1142_CR147","unstructured":"International Society for Infectious Diseases. Ebola, lab accident death - Russia (Siberia), May 22, 2004. Archive no. 20040522.1377. http:\/\/www.promedmail.org (2004)."},{"issue":"Suppl 1","key":"BFnm1142_CR148","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1086\/514316","volume":"179","author":"J Huggins","year":"1999","unstructured":"Huggins, J., Zhang, Z.X. & Bray, M. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model. J. Infect. Dis. 179 Suppl 1, S240\u2013S247 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR149","doi-asserted-by":"publisher","first-page":"A301","DOI":"10.1016\/0166-3542(95)94839-T","volume":"26","author":"JW Huggins","year":"1995","unstructured":"Huggins, J.W., Zhang, Z.X., Davis, K. & Coulombe, R.A. Inhibition of Ebola virus by S-adenosylhomocysteine hydrolase inhibitors. Antiviral Res. 26, A301 (1995).","journal-title":"Antiviral Res."},{"key":"BFnm1142_CR150","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jac\/14.suppl_A.27","volume":"14","author":"PG Canonico","year":"1984","unstructured":"Canonico, P.G., Kende, M., Luscri, B.J. & Huggins, J.W. In-vivo activity of antivirals against exotic RNA viral infections. J. Antimicrob. Chemother. 14, 27\u201341 (1984).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnm1142_CR151","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick, J.B. et al. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314, 20\u201326 (1986).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1142_CR152","unstructured":"Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. Morb. Mortal. Wkly. Rep. 37 Suppl 3, 1\u201316 (1988)."},{"issue":"Suppl 4","key":"BFnm1142_CR153","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","volume":"11","author":"JW Huggins","year":"1989","unstructured":"Huggins, J.W. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev. Infect. Dis. 11 Suppl 4, S750\u2013S761 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm1142_CR154","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0140-6736(95)91323-8","volume":"346","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch, S.P. et al. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346, 472\u2013475 (1995).","journal-title":"Lancet"},{"key":"BFnm1142_CR155","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/clind\/24.4.718","volume":"24","author":"PE Kilgore","year":"1997","unstructured":"Kilgore, P.E. et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24, 718\u2013722 (1997).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm1142_CR156","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1086\/375058","volume":"36","author":"M Mardani","year":"2003","unstructured":"Mardani, M., Jahromi, M.K., Naieni, K.H. & Zeinali, M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin. Infect. Dis. 36, 1613\u20131618 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm1142_CR157","first-page":"206","volume":"41","author":"GM Ignat'ev","year":"1996","unstructured":"Ignat'ev, G.M., Strel'tsova, M.A., Agafonov, A.P., Kashentseva, E.A. & Prozorovskii, N.S. Experimental study of possible treatment of Marburg hemorrhagic fever with desferal, ribavirin, and homologous interferon. Vopr. Virusol. 41, 206\u2013209 (1996).","journal-title":"Vopr. Virusol."},{"issue":"Suppl 1","key":"BFnm1142_CR158","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1086\/514310","volume":"179","author":"PB Jahrling","year":"1999","unstructured":"Jahrling, P.B. et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179 Suppl 1, S224\u2013S234 (1999).","journal-title":"J. Infect. Dis."},{"issue":"Suppl 4","key":"BFnm1142_CR159","doi-asserted-by":"publisher","first-page":"S815","DOI":"10.1093\/clinids\/11.Supplement_4.S815","volume":"11","author":"JC Morrill","year":"1989","unstructured":"Morrill, J.C., Jennings, G.B., Cosgriff, T.M., Gibbs, P.H. & Peters, C.J. (1989) Prevention of Rift Valley fever in rhesus monkeys with interferon-\u03b1. Rev. Infect. Dis. 11 Suppl 4, S815\u2013S825 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm1142_CR160","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/jir.1991.11.297","volume":"11","author":"JC Morrill","year":"1991","unstructured":"Morrill, J.C., Czarniecki, C.W. & Peters, C.J. Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. J. Interferon Res. 11, 297\u2013304 (1991).","journal-title":"J. Interferon Res."},{"key":"BFnm1142_CR161","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4269\/ajtmh.1970.19.677","volume":"19","author":"E Leifer","year":"1970","unstructured":"Leifer, E., Gocke, D.J. & Bourne, H. Lassa fever, a new virus disease in man from West Africa, II: report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am. J. Trop. Med. Hyg. 19, 677\u2013679 (1970).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1142_CR162","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/bmj.2.6086.541","volume":"2","author":"RT Emond","year":"1977","unstructured":"Emond, R.T., Evans, B., Bowen, E.T. & Lloyd, G. A case of Ebola virus infection. Br. Med. J. 2, 541\u2013544 (1977).","journal-title":"Br. Med. J."},{"key":"BFnm1142_CR163","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","volume":"2","author":"JI Maiztegui","year":"1979","unstructured":"Maiztegui, J.I., Fernandez, N.J. & de Damilano, A.J. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2, 1216\u20131217 (1979).","journal-title":"Lancet"},{"key":"BFnm1142_CR164","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(84)90299-X","volume":"2","author":"DA Enria","year":"1984","unstructured":"Enria, D.A., Briggiler, A.M., Fernandez, N.J., Lewis, S.C. & Maiztegui, J.I. Importance of dose of neutralizing antibodies in treatment of Argentine hemorrhagic fever with immune plasma. Lancet 2, 255\u2013256 (1984).","journal-title":"Lancet"},{"key":"BFnm1142_CR165","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0035-9203(84)90107-X","volume":"78","author":"JD Frame","year":"1984","unstructured":"Frame, J.D., Verbrugge, G.P., Gill, R.G. & Pinneo, L. The use of Lassa fever convalescent plasma in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 78, 319\u2013324 (1984).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"Suppl 1","key":"BFnm1142_CR166","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1086\/514298","volume":"179","author":"K Mupapa","year":"1999","unstructured":"Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J. Infect. Dis. 179 Suppl 1, S18\u2013S23 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnm1142_CR167","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0035-9203(72)90269-6","volume":"66","author":"HA White","year":"1972","unstructured":"White, H.A. Lassa fever: a study of 23 hospital cases. Trans. R. Soc. Trop. Med. Hyg. 66, 390\u2013401 (1972).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnm1142_CR168","first-page":"435","volume":"55","author":"AJ Clayton","year":"1977","unstructured":"Clayton, A.J. (1977) Lassa immune serum. Bull. World Health Organ. 55, 435\u2013439 (1977).","journal-title":"Bull. World Health Organ."},{"key":"BFnm1142_CR169","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0035-9203(85)90388-8","volume":"79","author":"PB Jahrling","year":"1985","unstructured":"Jahrling, P.B., Frame, J.D., Rhoderick, J.B. & Monson, M.H. Endemic Lassa fever in Liberia, IV: selection of optimally effective plasma for treatment by passive immunization. Trans. R. Soc. Trop. Med. Hyg. 79, 380\u2013384 (1985).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"Suppl 4","key":"BFnm1142_CR170","doi-asserted-by":"publisher","first-page":"S801","DOI":"10.1093\/clinids\/11.Supplement_4.S801","volume":"11","author":"AJ Shepherd","year":"1989","unstructured":"Shepherd, A.J., Swanepoel, R. & Leman, P.A. Antibody response in Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11 Suppl 4, S801\u2013S806 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"BFnm1142_CR171","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1073\/pnas.0402486101","volume":"101","author":"Q Ge","year":"2004","unstructured":"Ge, Q. et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101, 8676\u20138681 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1142_CR172","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.193.5.651","volume":"193","author":"Y Miura","year":"2001","unstructured":"Miura, Y. et al. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J. Exp. Med. 193, 651\u2013660 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm1142_CR173","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood.V96.6.2093","volume":"96","author":"Q Wang","year":"2000","unstructured":"Wang, Q., Miyakawa, Y., Fox, N. & Kaushansky, K. Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 96, 2093\u20132099 (2000).","journal-title":"Blood"},{"key":"BFnm1142_CR174","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","volume":"189","author":"N Kayagaki","year":"1999","unstructured":"Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H. & Okumura, K. & Yagita, H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189, 1451\u20131460 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm1142_CR175","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1086\/517704","volume":"27","author":"H-J Schnittler","year":"1998","unstructured":"Schnittler, H-J. & Feldmann, H. Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin. Infect. Dis. 27, 404\u2013406 (1998).","journal-title":"Clin. Infect. Dis."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T09:25:35Z","timestamp":1744363535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,30]]},"references-count":175,"journal-issue":{"issue":"S12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BFnm1142"],"URL":"https:\/\/doi.org\/10.1038\/nm1142","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,30]]},"assertion":[{"value":"30 November 2004","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}